Adaptimmune Therapeutics plc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| LONG FOCUS CAPITAL MANAGEMENT, LLC | 11/14/2025 | 18.58 M | $2.42 M | -21.80% | 7.03% |
| UBS GROUP AG | 11/13/2025 | 6.67 M | $866.76 K | 10,490.17% | 2.52% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2025 | 4.05 M | $527.03 K | 115.32% | 1.54% |
| MORGAN STANLEY | 11/14/2025 | 3.67 M | $476.59 K | -13.38% | 1.39% |
| JANE STREET GROUP, LLC | 11/14/2025 | 2.81 M | $364.69 K | 100.00% | 1.06% |
| ACADIAN ASSET MANAGEMENT LLC | 11/13/2025 | 1.49 M | $186.00 K | -24.39% | 0.56% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 1.32 M | $171.56 K | 15.59% | 0.50% |
| EMPIRICAL FINANCE, LLC | 11/13/2025 | 800.00 K | $104.00 K | 0.00% | 0.30% |
| B. RILEY WEALTH ADVISORS, INC. | 10/31/2025 | 500.00 K | $65.00 K | 100.00% | 0.19% |
| RATHBONES GROUP PLC | 11/13/2025 | 432.82 K | $56.27 K | 0.00% | 0.16% |
| FMR LLC | 11/13/2025 | 340.41 K | $44.25 K | -26.68% | 0.13% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 308.07 K | $40.05 K | 637.26% | 0.12% |
| CITADEL ADVISORS LLC | 11/14/2025 | 143.50 K | $18.66 K | 100.00% | 0.05% |
| CITADEL ADVISORS LLC | 11/14/2025 | 137.70 K | $17.90 K | 100.00% | 0.05% |
| LUMBARD & KELLNER, LLC | 11/12/2025 | 114.26 K | $14.85 K | 100.00% | 0.04% |
| LAKERIDGE WEALTH MANAGEMENT LLC | 10/17/2025 | 110.40 K | $14.35 K | 100.00% | 0.04% |
| XTX TOPCO LTD | 11/14/2025 | 102.50 K | $13.33 K | 28.09% | 0.04% |
| STATE OF TENNESSEE, TREASURY DEPARTMENT | 11/14/2025 | 73.38 K | $9.54 K | 0.00% | 0.03% |
| CAPTRUST FINANCIAL ADVISORS | 11/19/2025 | 68.72 K | $8.93 K | -13.10% | 0.03% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 67.03 K | $8.71 K | 0.00% | 0.03% |
| GROUP ONE TRADING, L.P. | 11/12/2025 | 61.73 K | $8.03 K | 100.00% | 0.02% |
| SEI INVESTMENTS CO | 11/13/2025 | 54.82 K | $7.13 K | 0.00% | 0.02% |
| STATE OF NEW JERSEY COMMON PENSION FUND D | 11/07/2025 | 54.72 K | $7.11 K | 0.00% | 0.02% |
| FEDERATION DES CAISSES DESJARDINS DU QUEBEC | 11/14/2025 | 53.19 K | $6.91 K | 0.00% | 0.02% |
| NORTHERN TRUST CORP | 11/14/2025 | 48.58 K | $6.32 K | -5.36% | 0.02% |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | 10/29/2025 | 40.82 K | $5.66 K | 277.37% | 0.02% |
| BLACKROCK, INC. | 11/12/2025 | 38.30 K | $4.98 K | -78.62% | 0.01% |
| COLUMBIA ADVISORY PARTNERS LLC | 10/24/2025 | 36.73 K | $4.78 K | 0.00% | 0.01% |
| SIMON QUICK ADVISORS, LLC | 10/21/2025 | 30.00 K | $3.90 K | 0.00% | 0.01% |
| SG AMERICAS SECURITIES, LLC | 10/23/2025 | 27.50 K | $4.00 K | 100.00% | 0.01% |
| RAYMOND JAMES FINANCIAL INC | 11/14/2025 | 25.26 K | $3.28 K | 0.00% | 0.01% |
| PROSPERITY WEALTH MANAGEMENT, INC. | 11/14/2025 | 19.23 K | $2.50 K | -2.71% | 0.01% |
| STONEX GROUP INC. | 11/14/2025 | 15.04 K | $1.96 K | 100.00% | 0.01% |
| TRAYNOR CAPITAL MANAGEMENT, INC. | 11/03/2025 | 15.00 K | $1.95 K | 100.00% | 0.01% |
| SIMPLEX TRADING, LLC | 11/12/2025 | 12.42 K | $1.00 K | 100.00% | 0.00% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 12.32 K | $1.60 K | 100.00% | 0.00% |
| ROCKEFELLER CAPITAL MANAGEMENT L.P. | 11/14/2025 | 12.17 K | $1.58 K | 100.00% | 0.00% |
| IFG ADVISORY, LLC | 11/12/2025 | 11.73 K | $1.52 K | 0.00% | 0.00% |
| X-SQUARE CAPITAL, LLC | 11/10/2025 | 11.57 K | $1.00 K | 3.58% | 0.00% |
| KORNITZER CAPITAL MANAGEMENT INC /KS | 10/31/2025 | 10.00 K | $1.30 K | 0.00% | 0.00% |
| RHUMBLINE ADVISERS | 11/06/2025 | 5.74 K | $745 | -32.70% | 0.00% |
| WELLS FARGO & COMPANY/MN | 11/13/2025 | 2.70 K | $351 | -94.48% | 0.00% |
| CITIGROUP INC | 11/10/2025 | 2.68 K | $348 | 100.00% | 0.00% |
| BARCLAYS PLC | 11/12/2025 | 2.53 K | $330 | 0.00% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 11/14/2025 | 2.06 K | $198 | -97.71% | 0.00% |
| RAIFFEISEN BANK INTERNATIONAL AG | 11/10/2025 | 907 | $118 | 100.00% | 0.00% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2025 | 700 | $91 | -93.59% | 0.00% |
| BRYN MAWR TRUST CO | 11/20/2025 | 604 | $79 | 0.00% | 0.00% |
| HIGHMARK WEALTH MANAGEMENT LLC | 10/20/2025 | 287 | $37 | 0.00% | 0.00% |
| PARALLEL ADVISORS, LLC | 11/13/2025 | 250 | $33 | 0.00% | 0.00% |
Adaptimmune Therapeutics plc institutional Ownership - FAQ's
During the previous two years, 100 institutional investors and hedge funds held shares of Adaptimmune Therapeutics plc. The most heavily invested institutionals were:
Long Focus Capital Management, LLC: 18.58 M
UBS Group AG: 6.67 M
RENAISSANCE TECHNOLOGIES LLC: 4.05 M
MORGAN STANLEY: 3.67 M
JANE STREET GROUP, LLC: 2.81 M
ACADIAN ASSET MANAGEMENT LLC: 1.49 M
15.94% of Adaptimmune Therapeutics plc stock is owned by institutional investors.
Institutional investors have bought a total of 42.71 M shares in the last 24 months. This purchase volume represents approximately $6.56 M in transactions.